TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
712,836
|
719,251
|
872,384 |
| Financial expenses |
9,589
|
1
|
30,027 |
| Earnings before taxes |
166,889
|
186,817
|
235,811 |
| EBITDA |
176,376
|
180,327
|
268,576 |
| Total assets |
608,985
|
672,567
|
580,083 |
| Current assets |
600,347
|
662,395
|
568,564 |
| Current liabilities |
355,893
|
257,536
|
266,381 |
| Equity capital |
243,687
|
406,254
|
305,788 |
| - share capital |
3,867
|
3,867
|
3,867 |
| Employees (average) |
85
|
92
|
93 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.0%
|
60.4%
|
52.7% |
| Turnover per employee |
8,386
|
7,818
|
9,380 |
| Profit as a percentage of turnover |
23.4%
|
26.0%
|
27.0% |
| Return on assets (ROA) |
29.0%
|
27.8%
|
45.8% |
| Current ratio |
168.7%
|
257.2%
|
213.4% |
| Return on equity (ROE) |
68.5%
|
46.0%
|
77.1% |
| Change turnover |
-6,415
|
-153,133
|
105,420 |
| Change turnover % |
-1%
|
-18%
|
14% |
| Chg. No. of employees |
-7
|
-1
|
-2 |
| Chg. No. of employees % |
-8%
|
-1%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.